Details of the Drug

General Information of Drug (ID: DM2DIYJ)

Drug Name

mRNA-1020

Indication

Disease Entry	ICD 11	Status	REF
Influenza	1E30-1E32	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Vaccine

Cross-matching ID

References

1	ClinicalTrials.gov (NCT05333289) Phase 1/2, Randomized, Observer-Blind, Dose-Ranging Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1020 and mRNA-1030 Candidate Seasonal Influenza Vaccines in Healthy Adults. U.S.National Institutes of Health.